Intersect ENT
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch Intersect ENT and buy or sell other stocks, ETFs, and their options commission-free!About XENT
Intersect ENT, Inc. is a commercial drug delivery company, which engages in the treatment of ear, nose, and throat conditions. Its products include PROPEL and SINUVA.
CEOThomas A. West, MBA
CEOThomas A. West, MBA
Employees—
Employees—
HeadquartersMenlo Park, California
HeadquartersMenlo Park, California
Founded2003
Founded2003
Employees—
Employees—
XENT Key Statistics
Market cap954.90M
Market cap954.90M
Price-Earnings ratio-5.63
Price-Earnings ratio-5.63
Dividend yield—
Dividend yield—
Average volume733.84K
Average volume733.84K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$28.25
52 Week high$28.25
52 Week low$15.92
52 Week low$15.92
Stock Snapshot
The current Intersect ENT(XENT) stock price is $28.24, with a market capitalization of 954.9M. The stock trades at a price-to-earnings (P/E) ratio of -5.63.
On 2025-12-06, Intersect ENT(XENT) stock opened at —, reached a high of —, and a low of —.
The Intersect ENT(XENT)'s current trading volume is 0, compared to an average daily volume of 733.84K.
In the last year, Intersect ENT(XENT) shares hit a 52-week high of $28.25 and a 52-week low of $15.92.
In the last year, Intersect ENT(XENT) shares hit a 52-week high of $28.25 and a 52-week low of $15.92.
People also own
Based on the portfolios of people who own XENT. This list is generated using Robinhood data, and it’s not a recommendation.